Getting ready for a strategic: a toolkit for medtech startups
Strategics can become partners, investors or acquirers. Learn what they look for and how your medtech startup can prepare, from regulatory strategy to IP.
-
-
Pathways to Exit: What We Learned at the 2026 MedTech Roadshow
What does it really take to build a medtech company that gets acquired, adopted and valued? Our 2026 MedTech Roadshow brought together founders, investors and industry leaders to explore the decisions that shape a company’s future long before exit — from regulatory and clinical strategy to commercialization, manufacturing and the real drivers of market adoption. With two stops on our 2026 tour: Houston,…
-
Talking with Corporate Strategics – Timing and IP Protection
When to Engage with Strategic Partners Build Relationships Early, Without Immediately Seeking Funding Establishing relationships with strategic investors early in your company’s development can be highly beneficial, even if you’re not immediately seeking investment. These relationships develop over time, and early engagement allows you to align long-term interests and facilitate smoother future transactions. By engaging…
-
2024 Medical Device Investment Data: A Brighter Exit Path, A Challenging Funding Road
Avio’s friends at Nocturnal wrote a great post on medtech funding in 2024 and what that could mean for 2025. Avio’s take? The pickup in M&A and (brief) return of IPOs are positives. Challenges with NIH funding, the FDA, and economic uncertainty are negatives. But you knew that already! What to do? Spend small money…
